Guselkumab - Janssen Biotech
At a glance
- Drug Originator MorphoSys
- Drug Licenced by Janssen Biotech; Taiho Pharmaceutical
- Drug Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Immunotherapies; Monoclonal antibodies; Skin disorder therapies; Urologics
- Mechanism of Action Interleukin-23 subunit p19 inhibitors
- USA Patent Applicants JANSSEN BIOTECH
- USA Patents 11
- BLAs 1
- International Patents 95

Disclaimer